DekaBank Deutsche Girozentrale’s Adverum Biotechnologies ADVM Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio ADVM Stock Details ADVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,250	Closed	-$113K	–	1368
2021 Q2	$113K	Sell	3,250 -1,000	-24%	-$53.9K	﹤0.01%	1316
2021 Q1	$397K	Buy	4,250 +1,000	+31%	+$120K	﹤0.01%	1064
2020 Q4	$380K	Buy	+3,250	New	+$402K	﹤0.01%	1078
2016 Q1	–	Sell	-1,290	Closed	-$122K	–	1056
2015 Q4	$122K	Hold	1,290	–	–	﹤0.01%	943
2015 Q3	$106K	Buy	1,290 +70	+6%	+$8.94K	﹤0.01%	964
2015 Q2	$198K	Buy	1,220 +40	+3%	+$13.5K	﹤0.01%	893
2015 Q1	$478K	Buy	+1,180	New	+$499K	0.01%	728

Other funds holding ADVM

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

SFI

Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DekaBank Deutsche Girozentrale's ADVM Position: Q3 2021 in Review

DekaBank Deutsche Girozentrale sold out of Adverum Biotechnologies (ADVM) in Q3 2021, closing a stake of 3,250 shares — an estimated $113K sold.

DekaBank Deutsche Girozentrale first reported a position in ADVM in Q1 2015 and held it in 7 quarters. The position peaked at $478K in Q1 2015. 110 funds tracked by Wall St. Rank hold ADVM as of Q3 2021.

DekaBank Deutsche Girozentrale reported no remaining Adverum Biotechnologies position as of Q3 2021 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 3,250 Adverum Biotechnologies shares in Q3 2021, an estimated $113K.
DekaBank Deutsche Girozentrale first reported a position in Adverum Biotechnologies in Q1 2015 and held it in 7 quarters.
DekaBank Deutsche Girozentrale's Adverum Biotechnologies position peaked at $478K in Q1 2015.
110 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q3 2021.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2021, filed 22 Oct 2021.